Literature DB >> 12479243

Molecular mechanisms of cardiac myofilament activation: modulation by pH and a troponin T mutant R92Q.

R John Solaro1, Jamie Varghese, A J Marian, Murali Chandra.   

Abstract

Activation of cardiac myofilaments is a complex process involving steric, allosteric, and cooperative mechanisms. The complexity of the protein-protein interactions that result in the rise and fall of tension in the heartbeat provide many points that may be modified by various control mechanisms. These include modulation by the sarcomere length, covalent modulation by protein phosphorylation and non-covalent modulation by the chemical environment surrounding the myofilaments. We focus here on effects of pH change in the context of one of the mutations in cardiac troponin T (R92Q) that causes familial hypertrophic cardiomyopathy (FHC). We tested whether this change in charge would manifest itself functionally by a difference in the pCa-force relations of skinned fiber bundles activated at pH values of 6.5, 7.0 and 7.5. Fiber bundles containing the cTnT-R92Q mutant demonstrated an increase in sensitivity to Ca2+ at all three pH values. However, the relative magnitude of the increase in Ca2+-sensitivity induced by the mutant cTnT increased as the pH was decreased from pH 7.5 to pH 7.0 and to pH 6.5. Maximum force generated by the myofilaments fell as pH was lowered over this range, but the percent fall in maximum force was the same for fiber bundles containing wild-type and mutant cTnT. Our results indicate that ischemia that may be associated with FHC may exacerbate the functional changes induced by the cTnT mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479243     DOI: 10.1007/s003950200038

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  11 in total

Review 1.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

2.  Phenotypic plasticity of sarcomeric protein mutations.

Authors:  Ali J Marian
Journal:  J Am Coll Cardiol       Date:  2007-06-11       Impact factor: 24.094

Review 3.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

4.  Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytes.

Authors:  Jose L Puglisi; Paul H Goldspink; Aldrin V Gomes; Megan S Utter; Donald M Bers; R John Solaro
Journal:  Arch Biochem Biophys       Date:  2014-01-27       Impact factor: 4.013

Review 5.  Experimental therapies in hypertrophic cardiomyopathy.

Authors:  Ali J Marian
Journal:  J Cardiovasc Transl Res       Date:  2009-10-01       Impact factor: 4.132

6.  Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice.

Authors:  Silvia Lutucuta; Natalia Tsybouleva; Masukuni Ishiyama; Gilberto Defreitas; Lei Wei; Blase Carabello; A J Marian
Journal:  J Am Coll Cardiol       Date:  2004-12-07       Impact factor: 24.094

7.  Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.

Authors:  Raffaella Lombardi; Achim Bell; Vinitha Senthil; Jasvinder Sidhu; Michela Noseda; Robert Roberts; Ali J Marian
Journal:  Cardiovasc Res       Date:  2008-03-18       Impact factor: 10.787

8.  Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.

Authors:  Ali J Marian; Vinitha Senthil; Suet N Chen; Raffaella Lombardi
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

9.  Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.

Authors:  Natalia Tsybouleva; Lianfeng Zhang; Suetnee Chen; Rajnikant Patel; Silvia Lutucuta; Shintaro Nemoto; Gilberto DeFreitas; Mark Entman; Blase A Carabello; Robert Roberts; A J Marian
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

10.  Molecular Genetic Basis of Hypertrophic Cardiomyopathy.

Authors:  A J Marian
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.